Scientific Publications Search Search Author Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Altmueller, Janine Dr.med. (41) Blankenstein, Thomas Prof. Dr. (15) Bunse, Mario Dr. (1) Fischer, Cornelius Dr. (1) Harabula, Izabela-Cezara (1) Kammertöns, Thomas Dr. (5) Kopp, Joachim Dr. (1) Leisegang, Matthias Prof. Dr. rer. nat. (1) Lupianez Garcia, Dario Jesus Dr. (1) Pezzutto, Antonio Prof. Dr. (1) Uckert, Wolfgang Prof. Dr. (2) (-) Willimsky, Gerald Dr. (5) 1997 (1) 1998 (1) 2000 (3) 2002 (1) 2005 (4) 2007 (1) 2008 (2) 2010 (4) 2011 (1) (-) 2013 (5) 2015 (1) 2017 (1) 2018 (4) 2019 (3) 2020 (3) 2021 (1) 2022 (8) 2023 (8) 2024 (3) Angiogenesis & Metabolism Laboratory (1) Biology of Malignant Lymphomas (1) Cellular Neurosciences (2) Computational Regulatory Genomics (1) Experimental Ultrahigh-Field MR (5) Genetics of Metabolic and Reproductive Disorders (1) Genome Engineering & Disease Models (2) Immune Regulation and Cancer (17) Integrative Vascular Biology (1) Magnetic Resonance (5) (-) Molecular Immunology and Gene Therapy (5) Proteome Dynamics (1) RNA Biology and Posttranscriptional Regulation (1) Transgenics (2) 5 Results: Active Filter: Willimsky, Gerald Dr.Molecular Immunology and Gene Therapy2013 Sort: Result score Newest to oldest Oldest to newest February 08, 2013 / Mol Med High immune response rates and decreased frequencies of regulatory T cells in metastatic renal cell carcinoma patients after tumor cell vaccination H. Pohla A. Buchner B. Stadlbauer B. Frankenberger S. Stevanovic S. Walter R. Frank T. Schwachula S. Olek J. Kopp G. Willimsky C.G. Stief A. Hofstetter A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel March 07, 2013 / Blood Differently immunogenic cancers in mice induce immature myeloid cells that suppress CTL in vitro but not in vivo following transfer K. Schmidt S. Zilio J.C. Schmollinger V. Bronte T. Blankenstein G. Willimsky February 05, 2013 / Proc Natl Acad Sci U S A Fas expression by tumor stroma is required for cancer eradication J.J. Listopad T. Kammertoens K. Anders B. Silkenstedt G. Willimsky K. Schmidt A.A. Kuehl C. Loddenkemper T. Blankenstein August, 2013 / Oncotarget Adoptive T-cell therapy to treat liver cancer: Is the liver microenvironment key? G. Willimsky U. Protzer P. Knolle M. Heikenwalder March 01, 2013 / J Clin Invest Virus-induced hepatocellular carcinomas cause antigen-specific local tolerance G. Willimsky K. Schmidt C. Loddenkemper J. Gellermann T. Blankenstein
February 08, 2013 / Mol Med High immune response rates and decreased frequencies of regulatory T cells in metastatic renal cell carcinoma patients after tumor cell vaccination H. Pohla A. Buchner B. Stadlbauer B. Frankenberger S. Stevanovic S. Walter R. Frank T. Schwachula S. Olek J. Kopp G. Willimsky C.G. Stief A. Hofstetter A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel
March 07, 2013 / Blood Differently immunogenic cancers in mice induce immature myeloid cells that suppress CTL in vitro but not in vivo following transfer K. Schmidt S. Zilio J.C. Schmollinger V. Bronte T. Blankenstein G. Willimsky
February 05, 2013 / Proc Natl Acad Sci U S A Fas expression by tumor stroma is required for cancer eradication J.J. Listopad T. Kammertoens K. Anders B. Silkenstedt G. Willimsky K. Schmidt A.A. Kuehl C. Loddenkemper T. Blankenstein
August, 2013 / Oncotarget Adoptive T-cell therapy to treat liver cancer: Is the liver microenvironment key? G. Willimsky U. Protzer P. Knolle M. Heikenwalder
March 01, 2013 / J Clin Invest Virus-induced hepatocellular carcinomas cause antigen-specific local tolerance G. Willimsky K. Schmidt C. Loddenkemper J. Gellermann T. Blankenstein